Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Timolol for Benign Vascular Periocular Lesions
NCT01250457Phase 4Withdrawn
- Sponsor
- Loyola University Chicago
- Start
- Jun 2010
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of timolol in rosacea, sponsored by Loyola University Chicago. Planned start Jun 2010; status: withdrawn.
02
Drugs
timolol
03
Conditions
rosacea
Beyond the preview
Go deeper on NCT01250457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01250457.